A ketamine session without integration therapy is like a profound conversation you never quite finish — the opening has been made, the window is there, but nothing is done to ensure that what was experienced translates into anything durable. At Nomad Therapeutics, integration therapy is not a supplemental offering; it is a foundational component of every patient’s care plan, positioned deliberately in the hours and days following each session to take full clinical advantage of the neuroplastic window that ketamine creates. The science behind why this matters is substantial, and we believe every patient deserves to understand it.
How Ketamine Opens a Neuroplastic Window
When ketamine is administered at sub-anesthetic, therapeutic doses, it triggers a rapid increase in brain-derived neurotrophic factor (BDNF) — a protein that promotes the formation of new synaptic connections and the reorganization of existing neural pathways. This neuroplastic surge is time-limited. It opens a window, typically spanning from the hours immediately after a session through several days following it, during which the brain is unusually receptive to new learning, new perspectives, and new emotional processing. Integration therapy is the structured effort to fill that window with meaningful clinical work.
Without integration, the neuroplastic window still opens — but it closes again without having been deliberately used. Patients may feel temporarily better after a session and then watch those benefits fade over days or weeks, not because the ketamine failed, but because the brain’s enhanced receptivity was not matched with the psychological work needed to consolidate lasting change. This is one reason why research comparing ketamine infusion alone to ketamine combined with psychotherapy consistently finds superior and more durable outcomes in the combined model. The drug creates an opportunity; therapy is what turns that opportunity into change.
What Integration Looks Like at Nomad Therapeutics
At Nomad Therapeutics, our integration sessions are structured therapeutic conversations — not generic check-ins or casual follow-ups. We approach them with the same intentionality we bring to the preparation sessions that precede each ketamine experience. In integration, we explore what emerged during the session: what thoughts, emotions, memories, or states arose, what felt significant, what felt confusing, and what might be worth sitting with further. We help patients connect the experiences of the ketamine state to patterns and insights that can be carried forward into daily life — into relationships, behaviors, self-understanding, and the narratives they hold about themselves and their struggles.
This is where the therapeutic framework that wraps ketamine use — referred to as the set and setting paradigm in the literature on psychedelic-assisted therapy — demonstrates its clinical value most clearly. The altered state produced by ketamine is not randomly meaningful. It is shaped by the patient’s intentions, their psychological readiness, and the quality of support they receive before and after. We invest heavily in all three factors because we have seen, and because the literature supports, that patients who arrive prepared and who integrate deliberately achieve outcomes that patients receiving medication alone rarely approach. Learn more about the three phases of ketamine-assisted psychotherapy — preparation, medicine session, and integration — that anchor our approach.
Addressing Emotional Avoidance Through Integration
One barrier that integration work specifically helps address is the difficulty many patients have with emotional avoidance — the reflexive turning away from distressing material that has become habitual over years of managing depression, anxiety, or trauma. Ketamine often loosens this avoidance temporarily, making emotional content more accessible and less threatening during and immediately after a session. Integration therapy is precisely the moment to engage that accessibility carefully, with clinical guidance, before the habitual defenses return. We meet patients in that openness and help them use it therapeutically.
A second barrier involves patients who worry that the insights or experiences they had during a ketamine session are too unusual, too difficult to describe, or too personal to discuss. We hear this concern and take it seriously. Our integration approach is patient-led: we follow the patient’s lead in exploring what matters to them, we do not impose meaning onto their experiences, and we create a space where all experiences — even those that felt frightening or confusing — are welcomed as clinically relevant information. Results vary by individual, and some patients find integration the most transformative part of their whole treatment experience, while others find it gradual and subtle. Both are valid paths toward therapeutic change.
Integration as Core to KAP for Treatment-Resistant Conditions
Our Seattle-area practice is built around patients who have lived for too long with the sense that their mental health treatment options are limited. For those patients, ketamine-assisted psychotherapy with genuine integration support is not a fringe approach — it is one of the most evidence-aligned and clinically thoughtful options currently available. Research continues to support its particular value for patients with treatment-resistant depression, anxiety, and PTSD, where conventional antidepressant regimens have fallen short. We approach every patient’s care with the full complexity it deserves, and we encourage anyone considering our program to discuss whether this model aligns with their treatment goals and needs.
For patients whose primary struggle is depression that has not responded to standard treatments, the question of durability is especially important. The evidence base on whether ketamine works for treatment-resistant depression increasingly points toward integrated models — where psychotherapy and medication work in concert — as producing the most meaningful and sustained relief. Integration is not a luxury layer on top of the medication; it is how the medication’s effects are consolidated into lasting clinical benefit.
Frequently Asked Questions
What exactly happens in a ketamine integration session?
Integration sessions are structured therapeutic conversations that explore what emerged during the ketamine experience — what thoughts, feelings, or insights arose, what felt meaningful or difficult, and how those experiences might connect to the patient’s broader therapeutic goals. We help patients translate experiences from the altered state into practical and emotional changes in everyday life.
How soon after a ketamine session should integration happen?
Integration is most effective when it begins relatively soon after a session — ideally within twenty-four to forty-eight hours, while the neuroplastic window and the emotional freshness of the experience are still available. We schedule integration sessions with this timing in mind.
Can I do integration work with my existing therapist in addition to Nomad Therapeutics?
Yes, in many cases this is an excellent complement. If your existing therapist is familiar with ketamine-assisted therapy or open to learning about it, their long-standing knowledge of your history can be a real asset in integration work. We welcome collaboration with existing providers.
Is integration therapy the same as regular psychotherapy?
Integration therapy shares many features with conventional psychotherapy but has a specific focus: using the neuroplastic window opened by ketamine to facilitate deeper or more rapid therapeutic movement than standard therapy alone typically produces. It is purposefully timed and structured around the ketamine sessions.
What if I don’t remember much about my ketamine session?
Memory of the ketamine experience is not required for integration to be productive. Many patients retain partial, impressionistic, or emotional memories rather than detailed narratives, and meaningful integration work can proceed from these. We work with whatever material the patient brings.
Key Takeaways
- Integration therapy is a structured therapeutic process timed to coincide with ketamine’s neuroplastic window — the period of enhanced brain receptivity following a session.
- Without integration, ketamine’s effects tend to be more transient; with it, patients achieve more durable therapeutic change.
- Nomad Therapeutics includes integration as a core component of every KAP program, not an optional add-on.
- Integration sessions help patients connect the experiences of the altered ketamine state to meaningful changes in daily life and long-standing patterns.
- Results vary by individual, and the integration process is patient-led, exploring what is most relevant to each person’s specific history and goals.
Take the Next Step
The neuroplastic window that ketamine creates is a genuine and time-limited opportunity — and what happens in the days after a session matters as much as the session itself. If you are in Seattle and considering ketamine-assisted psychotherapy, we invite you to think about what it would mean to have that opportunity met with skilled, dedicated integration support rather than left to unfold on its own. Contact Nomad Therapeutics today to learn more about our full KAP model and find out whether we are the right fit for your situation.
About Nomad Therapeutics
At Nomad Therapeutics in Seattle, our team delivers ketamine-assisted psychotherapy in the patient’s home, combining registered nurse–administered ketamine with preparation and integration therapy for a complete treatment model. We work specifically with patients who have not found adequate relief through conventional antidepressant treatment, starting every evaluation by taking the patient’s full history seriously and identifying what clinical picture it reveals. Our structured KAP model — preparation before each session, medication delivered by a nurse, and integration therapy afterward — is designed to make ketamine’s neuroplastic window translate into lasting therapeutic change for patients with treatment-resistant depression in the Seattle area.
Medical Disclaimer
The content on this page is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Ketamine therapy is not FDA-approved for psychiatric conditions including depression, anxiety, or PTSD; its use in these contexts is off-label and should be discussed thoroughly with a qualified healthcare provider. Results vary by individual, and no specific outcome is guaranteed. If you are experiencing a mental health crisis or emergency, please contact 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room. Always discuss treatment options, risks, and benefits with your provider before making any healthcare decisions.
References
Frontiers in Psychology, Psychedelic Integration Therapy: https://www.frontiersin.org/journals/psychology
National Institutes of Health, Neuroplasticity and Ketamine: https://pubmed.ncbi.nlm.nih.gov/
MAPS, Integration After Psychedelic Experiences: https://maps.org/
Journal of Psychedelic Studies: https://akjournals.com/journal/2559